RELUGOLIX for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 65 adverse event reports in the FDA FAERS database where RELUGOLIX was used for Neoplasm malignant.
Most Reported Side Effects for RELUGOLIX
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hot flush | 6,845 | 33.1% | 22 | 313 |
| Fatigue | 5,203 | 25.2% | 44 | 297 |
| Therapy interrupted | 3,251 | 15.7% | 20 | 99 |
| Incorrect dose administered | 1,917 | 9.3% | 39 | 204 |
| Asthenia | 1,718 | 8.3% | 25 | 182 |
| Arthralgia | 1,385 | 6.7% | 6 | 93 |
| Diarrhoea | 1,383 | 6.7% | 11 | 107 |
| Product dose omission issue | 1,189 | 5.8% | 16 | 155 |
| Dizziness | 1,146 | 5.6% | 10 | 105 |
| Constipation | 902 | 4.4% | 9 | 84 |
| Death | 832 | 4.0% | 832 | 74 |
| Weight increased | 805 | 3.9% | 3 | 42 |
| Insomnia | 764 | 3.7% | 3 | 60 |
| Pain | 750 | 3.6% | 13 | 101 |
| Myalgia | 721 | 3.5% | 5 | 44 |
Other Indications for RELUGOLIX
Prostate cancer (18,752)
Product used for unknown indication (1,417)
Uterine leiomyoma (115)
Prostate cancer metastatic (42)
Heavy menstrual bleeding (32)
Endometriosis (23)
Prostatic specific antigen increased (15)
Adenomyosis (14)
Hormone-refractory prostate cancer (13)
Anaemia (10)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)